Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
HealthEquity

HealthEquity (NASDAQ: HQY) insider transactions

In the twelve months to 10 November 2026, executives and directors of HealthEquity reported 13 open-market sales of 43,966 shares ($4.2m) and 2 open-market purchases of 131 shares ($11,942), by 6 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in HealthEquity shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
15 October 2026Rajasekar SunilEVP Chief Prod & Strat OfficerOpen-market purchase+108$90.3353,405Form 4
6 October 2026Neeleman StephenFounder and Vice ChairmanShares withheld for tax−1,095$91.16136,470Form 4
6 October 2026Lucania James MEVP & CFOShares withheld for tax−2,822$91.16101,795Form 4
6 October 2026Ladd DelanoEVP, General CounselShares withheld for tax−1,080$91.1688,974Form 4
6 October 2026Cutler ScottPresident and CEOShares withheld for tax−1,230$91.16175,175Form 4
6 October 2026Fiore Michael Henry—Shares withheld for tax−2,032$91.1650,212Form 4
6 October 2026Gathright MichaelChief Customer OfficerShares withheld for tax−662$91.1639,231Form 4
17 September 2026Neeleman StephenFounder and Vice ChairmanGift−1,500—408,235Form 4
25 August 2026Dillon Adrian TDirectorOption exercise, 10b5-1 plan+7,632$32.5070,027Form 4
25 August 2026Dillon Adrian TDirectorOpen-market sale, 10b5-1 plan−6,300$104.4763,727Form 4
25 August 2026Dillon Adrian TDirectorOpen-market sale, 10b5-1 plan−1,332$105.2662,395Form 4
24 August 2026Rajasekar SunilEVP Chief Prod & Strat OfficerOpen-market sale−108$105.6053,297Form 4
10 July 2026Fiore Michael HenryEVP, Chief Commercial OfficerOpen-market sale, 10b5-1 plan−2,354$95.0052,244Form 4
9 July 2026Gathright MichaelChief Customer OfficerShares withheld for tax−2,270$93.0739,893Form 4
8 July 2026Rajasekar SunilEVP Chief Prod & Strat OfficerOpen-market purchase+23$95.0653,405Form 4
8 July 2026Neeleman StephenFounder and Vice ChairmanShares withheld for tax−1,103$95.08137,565Form 4
8 July 2026Lucania James MEVP & CFOShares withheld for tax−2,839$95.08104,617Form 4
8 July 2026Ladd DelanoEVP, General CounselShares withheld for tax−1,087$95.0890,054Form 4
8 July 2026Cutler ScottPresident and CEOShares withheld for tax−1,238$95.08176,405Form 4
8 July 2026Fiore Michael HenryEVP, Chief Commercial OfficerShares withheld for tax−2,045$95.0854,598Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the HealthEquity page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.